{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:16:20Z","timestamp":1784945780992,"version":"3.55.0"},"reference-count":178,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction:<\/jats:title><jats:p>Different classes of psychotropics can cause hyperprolactinemia to varying degrees. Among antipsychotics, typical agents and risperidone are the most frequent and significant offenders. In this review we discuss the pathophysiology, offending medications, assessment and management of hyperprolactinemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We did a literature review between 1976 and 2008 using PubMed, MEDLINE, PsychINFO and Cochrane database. Search terms used were prolactin, hyperprolactinemia, psychotropics, antipsychotics, typical antipsychotics, atypical antipsychotics, antidepressants and SSRIs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Prolactin elevation is more common with antipsychotics than with other classes of drugs. Typical antipsychotics are more prone to cause hyperprolactinemia than atypical agents. Management options include discontinuation of offending medication, switching to another psychotropic, supplementing concurrent hormonal deficiencies and adding a dopamine agonist or aripiprazole.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Clinicians need to be alert about the potential for hyperprolactinemia and its manifestations with these medications. Prolactin levels need to be monitored and other causes of hyperprolactinemia ruled out in suspected cases. Copyright \u00a9 2010 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hup.1116","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T16:15:20Z","timestamp":1273162520000},"page":"281-297","source":"Crossref","is-referenced-by-count":108,"title":["Hyperprolactinemia associated with psychotropics\u2014a review"],"prefix":"10.1002","volume":"25","author":[{"given":"Subramoniam","family":"Madhusoodanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprit","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,6]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(76)90076-7"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(79)90028-3"},{"issue":"2","key":"e_1_2_16_4_1","first-page":"183","article-title":"Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats","volume":"41","author":"Aguilar E","year":"1985","journal-title":"Rev Esp Fisiol"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00086-4"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00175205"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0918f"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(83)90020-4"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300796"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.12.3507"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1981.00510080096021"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-4409(02)00403-4"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1982.tb03178.x"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.050682"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(00)00165-2"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01815271"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.126.3.285"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90373-1"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-827176"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198506000-00006"},{"issue":"2","key":"e_1_2_16_21_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ajp.156.2.294","article-title":"Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response","volume":"156","author":"Breier AF","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1826-6"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb02733.x"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.01.027"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1997.7.65"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(79)90056-8"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107078281"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1344-3"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200727010-00001"},{"issue":"8","key":"e_1_2_16_30_1","first-page":"556","article-title":"Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison","volume":"40","author":"Castelo\u2010Branco C","year":"1995","journal-title":"J Reprod Med"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0207"},{"key":"e_1_2_16_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb02115.x"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454601317261618"},{"issue":"1","key":"e_1_2_16_34_1","first-page":"143","article-title":"Antipsychotic\u2010induced hyperprolactinemia and sexual dysfunction","volume":"36","author":"Compton MT","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.01.051"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119701100410"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(97)00036-4"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780310068007"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00113-0"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80086-7"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbl037"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(91)90115-V"},{"issue":"6","key":"e_1_2_16_43_1","first-page":"429","article-title":"Effects of short\u2010term administration of valproate on serotonin\u20101A and dopamine receptor function in healthy human subjects","volume":"27","author":"Delva NJ","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90302-6"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016349109007893"},{"key":"e_1_2_16_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300412"},{"key":"e_1_2_16_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)90358-3"},{"key":"e_1_2_16_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2006.03.003"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000291502"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/003693308703200210"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197801262980408"},{"issue":"2","key":"e_1_2_16_52_1","first-page":"S97","article-title":"Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics","volume":"30","author":"Fric M","year":"2003","journal-title":"Psychiatr Prax"},{"issue":"6","key":"e_1_2_16_53_1","first-page":"252","article-title":"Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia","volume":"43","author":"Frye PE","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.27.521"},{"issue":"4","key":"e_1_2_16_55_1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00004714-199808000-00009","article-title":"An exploratory haloperidol\u2010controlled dose\u2010finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder","volume":"18","author":"Goff DC","year":"1998","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"e_1_2_16_56_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1358\/dot.1999.35.3.533849","article-title":"Quetiapine fumarate (Seroquel): a new atypical antipsychotic","volume":"35","author":"Goldstein JM","journal-title":"Drugs Today (Barc) (1999a)"},{"issue":"5","key":"e_1_2_16_57_1","first-page":"221","article-title":"Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health","volume":"44","author":"Goldstein SR","journal-title":"Int J Fertil Womens Med (1999b)"},{"key":"e_1_2_16_58_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.10.1381"},{"key":"e_1_2_16_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050610"},{"issue":"2","key":"e_1_2_16_60_1","first-page":"45","article-title":"Measurement of basal plasma levels of 3 anterior pituitary hormones during acute or chronic treatment with tricyclic antidepressants","volume":"11","author":"Goyot C","year":"1985","journal-title":"Encephale"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(82)90015-9"},{"issue":"3","key":"e_1_2_16_62_1","first-page":"A28","article-title":"Antidepressant\u2010induced hyperprolactinaemia","volume":"14","author":"Haddad P","year":"2000","journal-title":"J Psychopharmacol"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464200-00003"},{"key":"e_1_2_16_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200309000-00003"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199810030-00005"},{"issue":"1","key":"e_1_2_16_66_1","first-page":"107","article-title":"Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636)","volume":"32","author":"Hamner MB","year":"1996","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"e_1_2_16_67_1","first-page":"32","article-title":"Prolactin\u2010related and metabolic adverse effects of atypical antipsychotic agents","volume":"69","author":"Henderson DC","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02697-0"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb00754.x"},{"key":"e_1_2_16_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4179(92)90043-V"},{"key":"e_1_2_16_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)59165-1"},{"key":"e_1_2_16_72_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.7.921"},{"key":"e_1_2_16_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.6.553"},{"key":"e_1_2_16_74_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00390.x"},{"key":"e_1_2_16_75_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP.6.6.425"},{"issue":"1","key":"e_1_2_16_76_1","first-page":"E96","article-title":"Mechanism of verapamil calcium channel blockade\u2010induced hyperprolactinemia","volume":"270","author":"Kelley SR","year":"1996","journal-title":"Am J Physiol"},{"key":"e_1_2_16_77_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0506"},{"key":"e_1_2_16_78_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1105"},{"key":"e_1_2_16_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00127-0"},{"key":"e_1_2_16_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00128-2"},{"key":"e_1_2_16_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-8610(04)70344-8"},{"key":"e_1_2_16_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.12.006"},{"key":"e_1_2_16_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00011"},{"key":"e_1_2_16_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608283150903"},{"key":"e_1_2_16_85_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.1010"},{"issue":"1","key":"e_1_2_16_86_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00427479","article-title":"Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long\u2010term phenothiazine treatment","volume":"49","author":"Kolakowska T","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"e_1_2_16_87_1","first-page":"S38","article-title":"Flupenthixol\u2013a partial atypical neuroleptic?","volume":"68","author":"Kuhn KU","year":"2000","journal-title":"Fortschr Neurol Psychiatr"},{"key":"e_1_2_16_88_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C210"},{"key":"e_1_2_16_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199710000-00006"},{"key":"e_1_2_16_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90025-M"},{"key":"e_1_2_16_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00099-2"},{"key":"e_1_2_16_92_1","doi-asserted-by":"publisher","DOI":"10.1159\/000124712"},{"key":"e_1_2_16_93_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.235.21.2316"},{"key":"e_1_2_16_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(90)90069-H"},{"key":"e_1_2_16_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.02.001"},{"issue":"4","key":"e_1_2_16_96_1","first-page":"506","article-title":"Hyperprolactinemia and contraception: a prospective study","volume":"65","author":"Luciano AA","year":"1985","journal-title":"Obstet Gynecol"},{"key":"e_1_2_16_97_1","first-page":"15","article-title":"Hyperprolactinemia associated with risperidone a brief review","author":"Madhusoodanan S","year":"2007","journal-title":"Helix review series"},{"issue":"4","key":"e_1_2_16_98_1","first-page":"56","article-title":"Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences","volume":"63","author":"Maguire GA","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_2_16_99_1","first-page":"76","article-title":"Serum prolactin levels after a single and subchronic oral administration of chlorpromazine and sulpiride. A cross\u2010over study in healthy volunteers","volume":"28","author":"Mannisto PT","year":"1978","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_16_100_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.8.1334"},{"issue":"10","key":"e_1_2_16_101_1","first-page":"851","article-title":"Management of psychotropic\u2010induced hyperprolactinemia","volume":"11","author":"Marken PA","year":"1992","journal-title":"Clin Pharm"},{"key":"e_1_2_16_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00221-3"},{"key":"e_1_2_16_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)00264-4"},{"issue":"4","key":"e_1_2_16_104_1","first-page":"639","article-title":"Effects of bromocriptine on neuroleptic\u2010induced amenorrhea, galactorrhea and impotence","volume":"40","author":"Matsuoka I","year":"1986","journal-title":"Jpn J Psychiatry Neurol"},{"key":"e_1_2_16_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442822"},{"key":"e_1_2_16_106_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418130-00007"},{"key":"e_1_2_16_107_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0614"},{"key":"e_1_2_16_108_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770030003001"},{"issue":"2","key":"e_1_2_16_109_1","first-page":"268","article-title":"Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile","volume":"42","author":"Meltzer HY","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_16_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)90035-3"},{"key":"e_1_2_16_111_1","first-page":"303","article-title":"Effect of antidepressants on neuroendocrine axis in humans","volume":"32","author":"Meltzer HY","year":"1982","journal-title":"Adv Biochem Psychopharmacol"},{"key":"e_1_2_16_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(83)90001-X"},{"key":"e_1_2_16_113_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-6-1256"},{"key":"e_1_2_16_114_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900002340"},{"key":"e_1_2_16_115_1","doi-asserted-by":"publisher","DOI":"10.4065\/80.8.1050"},{"key":"e_1_2_16_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0106-6"},{"key":"e_1_2_16_117_1","volume-title":"Prolactin: Basic and Clinical Correlates","author":"Molitch ME","year":"1985"},{"key":"e_1_2_16_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(85)90087-3"},{"key":"e_1_2_16_119_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1108"},{"key":"e_1_2_16_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(02)00259-2"},{"key":"e_1_2_16_121_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198325040-00004"},{"key":"e_1_2_16_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70057-8"},{"key":"e_1_2_16_123_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145798001072"},{"key":"e_1_2_16_124_1","doi-asserted-by":"publisher","DOI":"10.1159\/000117733"},{"key":"e_1_2_16_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(87)90065-5"},{"key":"e_1_2_16_126_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199506000-00009"},{"issue":"10","key":"e_1_2_16_127_1","first-page":"379","article-title":"Relation of serum molindone levels to serum prolactin levels and antipsychotic response","volume":"50","author":"Pandurangi AK","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_16_128_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-3-1096"},{"key":"e_1_2_16_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.07.006"},{"issue":"4","key":"e_1_2_16_130_1","first-page":"202","article-title":"Hormonal and metabolic effects of transdermal estradiol\/progestagen administration in postmenopausal women","volume":"39","author":"Perrone G","year":"1994","journal-title":"Int J Fertil Menopausal Stud"},{"key":"e_1_2_16_131_1","doi-asserted-by":"publisher","DOI":"10.4065\/76.2.215"},{"key":"e_1_2_16_132_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2003023"},{"key":"e_1_2_16_133_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-1-181"},{"issue":"1","key":"e_1_2_16_134_1","first-page":"7","article-title":"Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans","volume":"93","author":"Polleri A","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_16_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051106"},{"key":"e_1_2_16_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(85)90515-6"},{"key":"e_1_2_16_137_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810070051009"},{"key":"e_1_2_16_138_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.3.249"},{"issue":"1","key":"e_1_2_16_139_1","first-page":"8","article-title":"Incidence of hyperprolactinemia during oral contraceptive therapy","volume":"55","author":"Reyniak JV","year":"1980","journal-title":"Obstet Gynecol"},{"key":"e_1_2_16_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(82)90093-6"},{"key":"e_1_2_16_141_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb01953.x"},{"key":"e_1_2_16_142_1","doi-asserted-by":"publisher","DOI":"10.1159\/000117828"},{"key":"e_1_2_16_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02043907"},{"key":"e_1_2_16_144_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760250077008"},{"key":"e_1_2_16_145_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00857.x"},{"issue":"5","key":"e_1_2_16_146_1","first-page":"584","article-title":"Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)","volume":"80","author":"Schlienger JL","year":"1980","journal-title":"Acta Psychiatr Belg"},{"key":"e_1_2_16_147_1","doi-asserted-by":"publisher","DOI":"10.1159\/000063574"},{"key":"e_1_2_16_148_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700106"},{"issue":"1","key":"e_1_2_16_149_1","first-page":"61","article-title":"Serum prolactin levels after buspirone in man","volume":"65","author":"Seppala T","year":"1987","journal-title":"Med Biol"},{"issue":"9","key":"e_1_2_16_150_1","first-page":"739","article-title":"Effects of high\u2010dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma","volume":"65","author":"Shamberger RC","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_16_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300203"},{"key":"e_1_2_16_152_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06071075"},{"key":"e_1_2_16_153_1","doi-asserted-by":"publisher","DOI":"10.1139\/y88-226"},{"issue":"5","key":"e_1_2_16_154_1","first-page":"332","article-title":"Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder","volume":"22","author":"Shlik J","year":"1997","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_16_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90956-4"},{"issue":"8","key":"e_1_2_16_156_1","first-page":"737","article-title":"Neuroleptic\u2010associated hyperprolactinemia. Can it be treated with bromocriptine?","volume":"37","author":"Smith S","year":"1992","journal-title":"J Reprod Med"},{"key":"e_1_2_16_157_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00002"},{"key":"e_1_2_16_158_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199708000-00009"},{"key":"e_1_2_16_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00066-0"},{"key":"e_1_2_16_160_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6019.1186"},{"key":"e_1_2_16_161_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2005.15.893"},{"key":"e_1_2_16_162_1","volume-title":"Olanzapine (Zyprexa\u00ae): a novel antipsychotic Lippincott","author":"Street J","year":"2000"},{"key":"e_1_2_16_163_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.15.3.375"},{"key":"e_1_2_16_164_1","doi-asserted-by":"publisher","DOI":"10.1159\/000179051"},{"key":"e_1_2_16_165_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-4-797"},{"key":"e_1_2_16_166_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.4.457"},{"key":"e_1_2_16_167_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345068"},{"issue":"5","key":"e_1_2_16_168_1","first-page":"929","article-title":"Pharmacological causes of hyperprolactinemia","volume":"3","author":"Torre DL","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_2_16_169_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199710000-00010"},{"key":"e_1_2_16_170_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.133"},{"key":"e_1_2_16_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90645-8"},{"issue":"8","key":"e_1_2_16_172_1","first-page":"2533","article-title":"Influence of endogenous opiates on anterior pituitary function","volume":"39","author":"Van Vugt DA","year":"1980","journal-title":"Fed Proc"},{"key":"e_1_2_16_173_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017126"},{"key":"e_1_2_16_174_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1542-a"},{"key":"e_1_2_16_175_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199408000-00007"},{"key":"e_1_2_16_176_1","first-page":"209","article-title":"Failure of bupropion to affect prolactin or growth hormone in man","author":"Whiteman PD","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_16_177_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7332.250"},{"key":"e_1_2_16_178_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.3.199"},{"key":"e_1_2_16_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(84)90050-7"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.1116","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.1116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:04:41Z","timestamp":1698663881000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.1116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,6]]},"references-count":178,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1002\/hup.1116"],"URL":"https:\/\/doi.org\/10.1002\/hup.1116","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,6]]}}}